458 related articles for article (PubMed ID: 19832688)
1. Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists.
Gerra G; Zaimovic A; Gerra ML; Ciccocioppo R; Cippitelli A; Serpelloni G; Somaini L
Recent Pat CNS Drug Discov; 2010 Jan; 5(1):46-52. PubMed ID: 19832688
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
3. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
4. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
5. Plant, synthetic, and endogenous cannabinoids in medicine.
Di Marzo V; Petrocellis LD
Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
[TBL] [Abstract][Full Text] [Related]
6. Medical Use of Cannabinoids.
Fraguas-Sánchez AI; Torres-Suárez AI
Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
[TBL] [Abstract][Full Text] [Related]
7. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
8. Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.
Ranieri R; Marasco D; Bifulco M; Malfitano AM
Recent Pat CNS Drug Discov; 2016; 10(2):157-177. PubMed ID: 27184693
[TBL] [Abstract][Full Text] [Related]
9. Role of endocannabinoid system in mental diseases.
Manzanares J; Urigüen L; Rubio G; Palomo T
Neurotox Res; 2004; 6(3):213-24. PubMed ID: 15325960
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system as a target for the treatment of cannabis dependence.
Clapper JR; Mangieri RA; Piomelli D
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):235-43. PubMed ID: 18691603
[TBL] [Abstract][Full Text] [Related]
12. Implication of cannabinoids in neurological diseases.
Alsasua del Valle A
Cell Mol Neurobiol; 2006; 26(4-6):579-91. PubMed ID: 16699878
[TBL] [Abstract][Full Text] [Related]
13. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
[TBL] [Abstract][Full Text] [Related]
14. Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.
Panagis G; Vlachou S; Nomikos GG
Curr Drug Abuse Rev; 2008 Nov; 1(3):350-74. PubMed ID: 19630731
[TBL] [Abstract][Full Text] [Related]
15. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
[TBL] [Abstract][Full Text] [Related]
16. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
Mendizábal VE; Adler-Graschinsky E
Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
[TBL] [Abstract][Full Text] [Related]
18. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
[No Abstract] [Full Text] [Related]
19. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
Jacobson MR; Watts JJ; Boileau I; Tong J; Mizrahi R
Eur Neuropsychopharmacol; 2019 Mar; 29(3):330-348. PubMed ID: 30635160
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system: emotion, learning and addiction.
Moreira FA; Lutz B
Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
